Unlock your academic potential and expand your network by joining us!

Domenico Tricarico

Prof. Domenico Tricarico

Section of Pharmacology, Department of Pharmacy-Pharmaceutical Sciences, Univers...

Share Link

Share

Information

The research interests of the Prof Domenico Tricarico focus on molecular target characterization through the pharmacology of ion channels involved in neuromuscular, metabolic acquired and genetic diseases, and in proliferative disturbances; toxicological and pharmacological investigation in vitro and in vivo, risk/benefit/cost analyses of experimental drugs and post-marketing surveillance through toxicological, pharmacovigilance, and pharmacoeconomic investigations; physiology/pharmacology/toxicology focusing on advanced ion channel biophysics, molecular biology, and pharmacology; skeletal muscle pathophysiology, pharmacology, and toxicology focusing on disorders affecting the neuromuscular apparatus, ion channel-related diseases, and insulin/glucose dysmetabolisms; and drug development focusing on the principles of drug development and the evaluation of experimental protocols in various therapeutic areaa.

Research Keywords & Expertise

Bone
Cell Cycle
Trp Channels
AKT
Ca2+-activated K+(BK) ...

Fingerprints

17%
Bone
10%
Cell Cycle
8%
AKT
8%
Ca2+-activated K+(BK) channel
5%
Cell volume
5%
KATP and Kir channels

Short Biography

The research interests of the Prof Domenico Tricarico focus on molecular target characterization through the pharmacology of ion channels involved in neuromuscular, metabolic acquired and genetic diseases, and in proliferative disturbances; toxicological and pharmacological investigation in vitro and in vivo, risk/benefit/cost analyses of experimental drugs and post-marketing surveillance through toxicological, pharmacovigilance, and pharmacoeconomic investigations; physiology/pharmacology/toxicology focusing on advanced ion channel biophysics, molecular biology, and pharmacology; skeletal muscle pathophysiology, pharmacology, and toxicology focusing on disorders affecting the neuromuscular apparatus, ion channel-related diseases, and insulin/glucose dysmetabolisms; and drug development focusing on the principles of drug development and the evaluation of experimental protocols in various therapeutic areaa.